RL
MindMaze Therapeutics Holding S.A.
RLFTF · OTC
$0.22 -15.85% (-$0.04)
Market Cap CHF 2.32M
P/E Ratio -
Div. Yield -
ROE 43.64%
Piotroski F-Score Moderate
4/9Valuation
100 /100
Cheap P/B 0.06x
P/S 0.28x
PEG N/A
Growth
78 /100
Growing Book val. growth 41.33%
Rev. growth 36.34%
FCF growth N/A
Profitability
20 /100
Weak FCF margin 36.69%
Op. margin 224.37%
Gross margin 69.41%
Quality
2 /100
Poor Asset turnover 0.16x
ROA 32.16%
ROIC 34.28%
Debt
69 /100
Low Current ratio 3.95x
Int. coverage -89.03x
Debt/Equity 0.06x
Stability
15 /100
Unstable Profitable years 0
EPS volatility 80.56%
Beta 1.23x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about RLFTF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Zach W. Henderson
Employees
10
Headquarters
Geneva